Polycystic ovarian disease.
D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis; D000728:Androgens / Q000378:metabolism; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D002996:Clomiphene / Q000627:therapeutic use; D003271:Contraceptive Agents, Female / Q000627:therapeutic use; D003272:Contraceptive Agents, Male / Q000627:therapeutic use; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D010053:Ovary / Q000473:pathology; D010062:Ovulation Induction; D011085:Polycystic Ovary Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D013148:Spironolactone / Q000627:therapeutic use
D000728:Androgens; D006063:Chorionic Gonadotropin; D003271:Contraceptive Agents, Female; D003272:Contraceptive Agents, Male; D002996:Clomiphene; D013148:Spironolactone; D017373:Cyproterone Acetate; D002927:Cimetidine; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D017258:Medroxyprogesterone Acetate; D003534:Cyproterone; D008525:Medroxyprogesterone